Firm Value and Geographic Competitive Advantage: Evidence from the U.S. Pharmaceutical Industry
49 Pages Posted: 5 Dec 2007
Abstract
This paper examines the effects of geographic sources of competitive advantage on firm value among publicly-traded pharmaceutical companies in the United States. A central argument is that firm value responds positively to geographic factors. We hypothesize that firm value is influenced by the degree of industry clustering, the availability of specialized business services, the presence of related or supporting industries, university and industrial R&D spending, and local demand. The empirical results lend support to our hypotheses. Specifically, the data show that companies located within major production clusters exhibit higher firm value than their counterparts located elsewhere. Even after controlling for the firm value determinants used by Fama and French (1998), geographic variables explain a significant part of the cross-sectional variation in firm value.
Keywords: Firm Value, Geographic Competitive Advantage
JEL Classification: G10, G30, L10, O18, O32, O33
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
The Stock Market Valuation of Research and Development Expenditures
By Louis K.c. Chan, Josef Lakonishok, ...
-
The Stock Market Valuation of Research and Development Expenditures
By Louis K.c. Chan, Josef Lakonishok, ...
-
The Risk and Return from Factors
By Louis K.c. Chan, J. Karaceski, ...
-
The R&D Master File Documentation
By Bronwyn H. Hall, Clint Cummins, ...
-
The Level and Persistence of Growth Rates
By Louis K.c. Chan, Jason J. Karceski, ...
-
R&D Accounting and the Tradeoff between Relevance and Objectivity
By Paul M. Healy, Stewart C. Myers, ...
-
R&D Reporting Biases and Their Consequences
By Baruch Lev, Bharat Sarath, ...
-
R&D Reporting Biases and Their Consequences
By Baruch Lev, Bharat Sarath, ...
-
Excess Returns to R&D-Intensive Firms
By Dennis J. Chambers, Ross Jennings, ...